World's Best Scientists 2026 revealed!
Leukemia
H-index 76

Leukemia

0887-6924

Published by: Springer

https://www.nature.com/leu/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 33 147 191 38
Medicine 87 807 1276 75

Additional Metrics

Number of Best Scientists*: 1495
Documents by Best Scientists*: 1574
Top 100 Ranked Scientists*: 45
SCIMAGO H-index: 229
SCIMAGO SJR: 3.458
Impact Factor: 13.4

Overview

Top Research Topics at Leukemia?

The journal primarily focuses on research topics in Cancer research, Immunology, Internal medicine, Leukemia and Molecular biology. Leukemia holds forums on Cancer research that merges themes from other disciplines such as Cell culture, Cell growth, Mutation, Apoptosis and Signal transduction. Issues in Immunology were discussed, taking into consideration concepts from other disciplines like Haematopoiesis and Transplantation.

The work on Haematopoiesis presented is anchored in Stem cell and Cell biology. The concepts on Internal medicine presented in Leukemia can also apply to other research fields, including Gastroenterology, Surgery and Oncology. The journal explores issues in Leukemia which can be linked to other research areas like Myeloid, Lymphoma, Pathology and Myeloid leukemia.

The close relationship between Chromosomal translocation and Cytogenetics is one of the points of interest dissected in Molecular biology research. Leukemia focuses on Hematology research which is adjacent to topics in Cancer. Acute lymphocytic leukemia study tackled is connected to the field of Acute leukemia.

  • Cancer research (32.50%)
  • Immunology (30.34%)
  • Internal medicine (29.67%)

What are the most cited papers published in the journal?

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. (2520 citations)
  • International uniform response criteria for multiple myeloma (2124 citations)
  • Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program (1300 citations)

Research areas of the most cited articles at Leukemia:

The most cited papers mostly deal with topics like Internal medicine, Immunology, Cancer research, Leukemia and Myeloid leukemia. The studies on Immunology discussed at the published papers can also contribute to research in the domains of Haematopoiesis and Stem cell. The featured Leukemia studies in the most cited articles mainly concentrate on Molecular biology but also cover areas of interest in Gene rearrangement.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Cancer

The previous edition focused in particular on these issues:

The primary areas of discussion in the journal are Internal medicine, Cancer research, Oncology, Myeloid leukemia and Leukemia. While work presented in the journal provided substantial information on Internal medicine, it also covered topics in Gastroenterology, Text mining and MEDLINE. The research on Cancer research tackled can also make contributions to studies in the areas of Haematopoiesis, Stem cell, T cell, Chronic lymphocytic leukemia and Multiple myeloma.

The journal focused on Haematopoiesis research but expanded to cover Bone marrow. The studies in Oncology featured incorporate elements of Clinical trial, Disease, Cohort and Lymphoma. The work on Myeloid leukemia addressed in Leukemia expands to the thematically related Myeloid.

The most cited articles from the last journal are:

  • CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. (33 citations)
  • Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis. (31 citations)
  • Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. (30 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Leukemia (based on the number of publications) are:

  • Hagop M. Kantarjian (159 papers) published 10 papers at the last edition, 6 more than at the previous edition,
  • Andreas Hochhaus (131 papers) published 6 papers at the last edition, 11 less than at the previous edition,
  • Pierre Fenaux (118 papers) published 7 papers at the last edition, 5 more than at the previous edition,
  • J J M van Dongen (112 papers) absent at the last edition,
  • Hartmut Döhner (98 papers) published 7 papers at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Leukemia (based on the number of publications) are:

  • French Institute of Health and Medical Research (496 papers) published 17 papers at the last edition, 3 more than at the previous edition,
  • University of Texas MD Anderson Cancer Center (491 papers) published 35 papers at the last edition, 18 more than at the previous edition,
  • Mayo Clinic (467 papers) published 30 papers at the last edition, 5 more than at the previous edition,
  • Harvard University (460 papers) published 38 papers at the last edition, 13 more than at the previous edition,
  • Boston Children's Hospital (443 papers) published 20 papers at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.14% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 35.01% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.38% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.69% of all publications and 33.92% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

    (2022)
    3421 Citations
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

    (2022)
    3202 Citations
  • European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    Andreas Hochhaus;Michele Baccarani;Richard T. Silver;Charles A. Schiffer

    (2020)
    1218 Citations
  • COVID-19 in persons with haematological cancers.

    Wenjuan He;Lei Chen;Li Chen;Guolin Yuan

    (2020)
    510 Citations
  • Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

    Jan A. Burger;Paul M. Barr;Tadeusz Robak;Carolyn Owen

    (2020)
    421 Citations
  • B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches.

    Nina Shah;Ajai Chari;Emma Scott;Khalid Mezzi

    (2020)
    379 Citations
  • MDM2 inhibition: an important step forward in cancer therapy

    Marina Konopleva;Giovanni Martinelli;Naval Daver;Cristina Papayannidis

    (2020)
    292 Citations
  • COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.

    Lydia Scarfò;Thomas Chatzikonstantinou;Gian Matteo Rigolin;Giulia Quaresmini

    (2020)
    288 Citations
  • Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.

    Huan Li;Chongxiang Chen;Fang Hu;Jiaojiao Wang

    (2020)
    270 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical knowledge or careers beyond traditional medicine, there are several online degree programs worth considering. Aspiring nurses can explore top-tier online ASN programs, which offer flexible training to enter the healthcare workforce efficiently. These online ASN options are designed for accessibility without compromising quality.

Nutrition plays a vital role in healthcare, and becoming a registered dietitian opens diverse career pathways. Many universities now offer some of the best online registered dietitian programs to suit busy students who wish to learn at their own pace while maintaining strong scientific foundations.

Healthcare administration is another key sector supporting medical services. For professionals aiming to climb the administrative ladder, enrolling in CAHME accredited MHA programs online offers comprehensive training in managing healthcare organizations effectively.

Finally, advanced nursing practitioners seeking a Doctor of Nursing Practice can benefit from flexible schedules through online DNP programs without dissertation. These programs focus on clinical leadership and real-world impact without the traditional dissertation barrier.

Best Scientists Contributing to This Journal

Recently Published Articles